Global Neurological Biomarkers Market to Grow at 13.5% During 2022-2027, Impelled by Increasing Incidences of Neurological Disorders

August 16, 2021

According to the latest report by IMARC Group, titled "Neurological Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global neurological biomarkers market is expected to grow at a CAGR of 13.5% during 2022-2027. Neurological biomarkers refer to measurable indicators that are utilized to examine normal biological processes, pathogenic processes, and the pharmacologic responses to a therapeutic intervention. These molecules are present in the blood or cerebral spinal fluid (CSF) that aid in detecting biological responses to experimental drugs. They are commonly utilized for diagnosing brain disorders and monitoring disease progression in patients. The main sources of neurological biomarkers include metabolite levels, brain imaging, genetic mutations, and changes in protein expression or post-translational modifications that are extensively utilized by researchers for non-invasive testing and formulating personalized treatment plans.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Neurological Biomarkers Market Trends:

The global market is majorly driven by the increasing incidences of neurological disorders across the globe. The rising prevalence of stroke, motor neuron disease (MND), Alzheimer’s disease (AD), and Parkinson’s disease (PD) among the masses have resulted in the growing demand for effective treatment plans and the escalating need for faster drug development. Since neurological biomarkers are widely used to measure the efficacy of new drugs and therapeutic strategies, this is creating a positive outlook for the market. Moreover, the increasing healthcare expenditure on the global level and the rising demand for personalized medicine are acting as major growth-inducing factors. The market is further driven by the widespread preference for digital biomarkers and the advent of newer neurological biomarkers that are expected to assist neuropathologists in the selection and characterization of suitable treatment strategies. Apart from this, continual advancements in mass spectrometry and imaging procedures are anticipated to offer faster evaluation of biochemical markers and structural changes in the brain, thereby creating a positive outlook for the market.

Market Summary:

  • On the basis of the type, the market has been divided into genomic biomarkers, proteomic biomarkers, metabolomic biomarkers, imaging biomarkers, and others.
  • Based on the application, the market has been classified into Alzheimer's disease, Parkinson's disease, multiple sclerosis, autism spectrum disorders, and others.
  • On the basis of the end use, the market has been categorized into hospital laboratories, clinical diagnostic centers, research organizations, and others.
  • On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Abbott Laboratories, Acumen Pharmaceuticals Inc., Athena Diagnostics (Quest Diagnostics), Banyan Biomarkers Inc., Bio-Rad Laboratories Inc., Immunarray Pvt. Ltd., Myriad Rbm, Inc. (Myriad Genetics Inc.), Proteome Sciences Plc and Thermo Fisher Scientific Inc.


About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Global Neurological Biomarkers Market to Grow at 13.5% During 2022-2027, Impelled by Increasing Incidences of Neurological Disorders
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More